Cardio-oncology is the evolving discipline focused on the intersection of cardiovascular disease (CVD) and cancer. Cardiovascular diseases increase the risk of complications of cancer treatment, and cancer treatment itself can cause cardiovascular diseases.
On average, 20 percent of patients receiving certain classes of anticancer therapies may experience cardiac adverse effects that manifest as either an acute toxic effect or potentially a late complication. On the flip side, pre-existing cardiac conditions or risk factors may limit available therapeutic options for cancer treatment.
Some of the same factors cause both cardiovascular disease and cancer. For the first time, clinicians and researchers are starting to link these previously unrelated diseases.
- Duke Cardio-Oncology News Issue 4 :: 2/17
- Duke Cardio-Oncology News Issue 3 :: 8/16
- Duke Cardio-Oncology News Issue 2 :: 2/16
- Duke Cardio-Oncology News Issue 1 :: 8/15
Duke Cardio-Oncology News is a joint bi-yearly publication of Duke Cancer Institute and Duke Division of Cardiology. To subscribe, please contact Chiara Melloni, MD, MHS.